A phase I pharmacokinetic and pharmacodynamic study of OGX-011, a 2'-methoxyethyl antisense oligonucleotide to clusterin, in patients with localized prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16145049

J. Natl. Cancer Inst. 2005 Sep 7 97 17 1287-96

Download in:

View as

Triples

General Info

PMID
16145049